Benzoxazole and benzothiazole derivatives as 5-hydroxytrytamine-6 ligands

Details for Australian Patent Application No. 2007255041 (hide)

Owner Wyeth

Inventors Elokdah, Hassan Mahmoud; Robichaud, Albert Jean; Liu, Kevin

Agent Davies Collison Cave

Pub. Number AU-A-2007255041

PCT Pub. Number WO2007/142904

Priority 60/809,996 01.06.06 US

Filing date 25 May 2007

Wipo publication date 13 December 2007

International Classifications

A61K 31/423 (2006.01) - condensed with carbocyclic rings

A61K 31/428 (2006.01) - condensed with carbocyclic rings

C07D 263/58 (2006.01) Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings

C07D 277/82 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

Event Publications

8 January 2009 PCT application entered the National Phase

  PCT publication WO2007/142904 Priority application(s): WO2007/142904

9 June 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007255042-1-sulfonylindazolylamine and -amide derivatives as 5-hydroxytryptamine-6 ligands

2007255038-Regulation of transforming growth factor-beta (TGF-beta) gene expression in living cells via the application of specific and selective electric and electromagnetic fields